Browse by Speaker

Type here to filter the list

B
Badgwell, Brian

The University of Texas MD Anderson Cancer Center
100: Robotic Subtotal Gastrectomy with D2 Lymph Node Dissection using Indocyanine Green Sentinel Lymphatic Mapping
Location:Veterans Memorial Auditorium
Brian Badgwell
PRO
Location:Veterans Memorial Auditorium
Brian Badgwell
Rebuttal and Q&A
Location:Veterans Memorial Auditorium
Brian Badgwell
Baecher, Kirsten

Emory University School of Medicine, Department of Surgery, Atlanta, GA, USA
P41: A Multi-Institution Observational Analysis of the Theory of the Immunization Effect in Patients with Multiple Primary Melanomas
Location:SSO HUB: Melanoma & Sarcoma Zone
Kirsten Baecher
Bagaria, Sanjay

Mayo Clinic
P63: Is there a benefit to radiation and surgery in specific histologic subtypes of retroperitoneal sarcoma?
Location:SSO HUB: Melanoma & Sarcoma Zone
Sanjay Bagaria
Bahary, Nathan

Allegheny Health Network
P55: Defining Values and Quality of Life of Cancer Survivors following Cytoreductive Surgery and HIPEC: An International Study
Location:SSO HUB: Rare/Metastatic Cancers Zone
Nathan Bahary
Baia, Marco

University Hospitals Birmingham NHS Foundation Trust
P62: Risk Factors for the Development of Early Recurrence in Patients with Primary Retroperitoneal Sarcoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Marco Baia
Bailey, Christina

Vanderbilt University Medical Center
23: Single-cell RNA Sequencing Reveals Distinct Populations of Tumor Associated Macrophages in Colorectal Metastasis.
Location:Ballroom C
Christina Bailey
P21: Utility of near infrared autofluorescence detection of small bowel neuroendocrine tumors to guide extent of resection
Location:SSO HUB: Breast & Endocrine Zone
Christina Bailey
Baker, Erin

Atrium Health
47: Surgical Microwave Ablation for Treatment of Hepatocellular Carcinoma: A Single Institution Review from 2006-2022
Location:Ballroom A
Erin Baker
Balachandran, Vinod

Memorial Sloan Kettering Cancer Center
The Next Generation of Vaccination Approaches to the Treatment of Cancer: mRNA and Designer Cancer Vaccines
Location:SSO HUB: Immuno-Oncology Zone
Vinod Balachandran
Balch, Glen

Winship Cancer Institute, Emory University
26: Neoadjuvant Chemoradiation Does Not Improve Outcomes for Patients Undergoing Resection for Upper Rectal Cancer: A US Rectal Cancer Consortium Analysis
Location:Ballroom C
Glen Balch
Baldonado, Jobelle

Moffitt Cancer Center
97: Long-term Oncologic Outcomes Following Pathologic Complete Response (pCR) for Esophageal Cancer
Location:Ballroom A
Jobelle Baldonado
Ballmam, Karla

Weill Cornell MMedical Center
1: Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer – Results from ACOSOG Z11102 (Alliance)
Location:Veterans Memorial Auditorium
Karla Ballmam
Bamford, Mark

University Hospitals of Leicester NHS Trust, Leicester, UK
62: Validation of Invasive Area for Predicting Sentinel Node Status and Survival in Melanoma
Location:Veterans Memorial Auditorium
Mark Bamford
Bansal, Rani

Duke University
P7: Genomic characterization of breast cancer metastases reveals differences in rates of PIK3CA mutation across metastatic sites and worse survival in patients with concurrent CDH1 mutation treated with PI3K inhibitor
Location:SSO HUB: Breast & Endocrine Zone
Rani Bansal
Bansal, Varun

Division of Surgical Oncology, Yale University
P53: Therapeutic Implications of Germline Testing in Peritoneal Mesothelioma
Location:SSO HUB: Rare/Metastatic Cancers Zone
Varun Bansal
Bao, Matthew

Duke University
P33: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Matthew Bao
Barabash, Victoria

Sunnybrook research institute
84: The association between familiarity of the surgeon-anesthesiologist dyad and post-operative patient outcomes for complex gastrointestinal cancer surgery: a population-based study.
Location:Ballroom B
Victoria Barabash
Barakat, Philipp

Mercy Medical Center
24: Sufficient Regional Lymph Node Examination for Staging High-Grade Appendix Cancer
Location:Ballroom C
Philipp Barakat
Barisella, Marta

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
P64: Surgical management of the duodenum during multivisceral resection for retroperitoneal sarcoma (RPS)
Location:SSO HUB: Melanoma & Sarcoma Zone
Marta Barisella
Barnett, Carlton

University of Colorado
P38: Dynamic anthropometrics: sarcopenia and survival in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Carlton Barnett
Barrio, Andrea

Memorial Sloan Kettering Cancer Center
P1: Axillary dissection is avoidable in the majority of cT1N0 triple negative and HER2+ breast cancers having upfront surgery with adjuvant radiation
Location:SSO HUB: Breast & Endocrine Zone
Andrea Barrio
P3: Diagnosing lymphedema after axillary surgery: which method is superior?
Location:SSO HUB: Breast & Endocrine Zone
Andrea Barrio
Barry-Hundeyin, Mautin

Department of Surgery, The University of Kentucky College of Medicine
P36: Campylobacter abundance is associated with an inflammatory immune signature in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Mautin Barry-Hundeyin
P40: Exosomal isolation of immune checkpoints from pancreatic ductal adenocarcinoma patient-derived organoids
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Mautin Barry-Hundeyin
Bartholomew, Alex

Duke University Medical Center
77: Current Patterns of Care and Outcomes for Dermatofibrosarcoma Protuberans: An International Multi-institutional Collaborative
Location:Ballroom A
Alex Bartholomew
P60: Evolution in management of upfront treatment for desmoid tumors
Location:SSO HUB: Melanoma & Sarcoma Zone
Alex Bartholomew
P79: Impact of Tumor Size and Management on Survival in Gastric GIST
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Alex Bartholomew
Bartlett, David

Allegheny Health Network Cancer Institute
65: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH Sensitive Imaging Agent: Topline Results from a Phase 2 Study
Location:Veterans Memorial Auditorium
David Bartlett
69: Peritoneal fluid cytokine analysis reveals targets for regional immunotherapy in carcinomatosis
Location:Ballroom B
David Bartlett
73: Predicting Early Recurrence to optimize Patient Selection for Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy in High-Grade Appendiceal Mucinous Carcinoma Peritonei
Location:Ballroom B
David Bartlett
P52: Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases
Location:SSO HUB: Rare/Metastatic Cancers Zone
David Bartlett
P55: Defining Values and Quality of Life of Cancer Survivors following Cytoreductive Surgery and HIPEC: An International Study
Location:SSO HUB: Rare/Metastatic Cancers Zone
David Bartlett
P56: A Data Driven Approach for Individualized Risk Prediction of Serious Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Location:SSO HUB: Rare/Metastatic Cancers Zone
David Bartlett
Bartlett, Edmund

Memorial Sloan Kettering Cancer Center
58: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?
Location:Veterans Memorial Auditorium
Edmund Bartlett
74: Interim Results of a Phase II Trial of Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Patients with Extremity Sarcoma
Location:Veterans Memorial Auditorium
Edmund Bartlett
P42: Clinical Benefit of Sentinel Lymph Node Biopsy Nomograms for Head and Neck Melanoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Edmund Bartlett
Basik, Mark

Department of Surgery, McGill University Medical School, Montreal, QC, Canada; Department of Oncology, McGill University Medical School, Montreal, QC, Canada
P12: Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast Conserving Surgery After Neoadjuvant Chemotherapy
Location:SSO HUB: Breast & Endocrine Zone
Mark Basik
Bassel, Miranda

McGill University
P12: Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast Conserving Surgery After Neoadjuvant Chemotherapy
Location:SSO HUB: Breast & Endocrine Zone
Miranda Bassel
Bassett, Paul

Statsconsultancy
P62: Risk Factors for the Development of Early Recurrence in Patients with Primary Retroperitoneal Sarcoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Paul Bassett
Bauer-Rowe, Khristian

Stanford University
39: Mechanoresponsive Pancreatic Ductal Adenocarcinoma Cancer Associated Fibroblasts Shows an FAK-Dependent Subtype Divergent from Canonical Fibrotic TGFB-Pathway Dependence
Location:Ballroom B
Khristian Bauer-Rowe
Bayard, Solange

New York-Presbyterian Weill Cornell Medicine
P8: Breast Cancer Among Asian Women in New York City: Disparities in Presentation and the Need for Disaggregated Data
Location:SSO HUB: Breast & Endocrine Zone
Solange Bayard
Beane, Joal

The Ohio State University Wexner Medical Center- Division of Surgical Oncology
34: An Artificial Intelligence Approach to Determining Optimal Margin Width in Patients Undergoing Hepatectomy for Intrahepatic Cholangiocarcinoma
Location:Veterans Memorial Auditorium
Joal Beane
67: Molecular mechanism of colorectal peritoneal metastasis: an interesting TWIST
Location:Ballroom B
Joal Beane
80: Disparities in Socioeconomic Mediation of Racial Segregation in Hepatopancreaticobiliary Cancer
Location:Veterans Memorial Auditorium
Joal Beane
82: Socioeconomic Disparities in the Treatment and Survival of Extremity Soft Tissue Sarcoma
Location:Ballroom B
Joal Beane
P57: Phosphorylation of IWS1 by AKT Maintains Liposarcoma Tumor Heterogeneity through Preservation of Cancer Stem Cell Phenotypes and Mesenchymal-Epithelial Plasticity
Location:SSO HUB: Melanoma & Sarcoma Zone
Joal Beane
P59: Comparing complete compartmental resection with tumor only resection of retroperitoneal soft tissue sarcoma using the win ratio
Location:SSO HUB: Melanoma & Sarcoma Zone
Joal Beane
P68: The Impact of Digital Inequities on Gastrointestinal Cancer Disparities in the US
Location:SSO HUB: Rare/Metastatic Cancers Zone
Joal Beane
Beasley, Georgia

Duke University
58: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?
Location:Veterans Memorial Auditorium
Georgia Beasley
60: Safety, efficacy, and biomarker assessment of RP1 in combination with nivolumab in patients with advanced skin cancers
Location:Veterans Memorial Auditorium
Georgia Beasley
Melanoma Great Debate: Limb Infusion: A Thing of the Past?
Location:Ballroom C
Georgia Beasley
P41: A Multi-Institution Observational Analysis of the Theory of the Immunization Effect in Patients with Multiple Primary Melanomas
Location:SSO HUB: Melanoma & Sarcoma Zone
Georgia Beasley
Beauchamp, Robert D.

VUMC
23: Single-cell RNA Sequencing Reveals Distinct Populations of Tumor Associated Macrophages in Colorectal Metastasis.
Location:Ballroom C
Robert D. Beauchamp
Bea, Vivian

New York-Presbyterian Brooklyn Methodist Hospital
Breast Parallel Session 2
Location:Veterans Memorial Auditorium
Vivian Bea
Beckman, Michael

Atrium Health Carolinas Medical Center
47: Surgical Microwave Ablation for Treatment of Hepatocellular Carcinoma: A Single Institution Review from 2006-2022
Location:Ballroom A
Michael Beckman
Bednarski, Brian

The University of Texas MD Anderson Cancer Center
Colorectal Parallel Session
Location:Ballroom C
Brian Bednarski
Bedrosian, Isabelle

The University of Texas MD Anderson Cancer Center
16: Association of Medicaid Expansion with reduction in racial disparities in the timely delivery of up-front surgical care for patients with early stage breast cancer
Location:Veterans Memorial Auditorium
Isabelle Bedrosian
Beekman, Kate

University of South Florida
58: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?
Location:Veterans Memorial Auditorium
Kate Beekman
Beets, Geerard

The Netherlands Cancer Institute
Managing a Near Complete Response
Location:Ballroom B
Geerard Beets
Questions and Discussions
Location:Ballroom B
Geerard Beets
Behman, Ramy

University of Toronto
P16: The role of anastomotic leak as a potential high-risk criteria in Stage II colon cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Ramy Behman
Behrens, Shay

National Cancer Institute
P74: Perceptions of Readiness for Practice after Complex General Surgical Oncology Fellowship: A Survey Study
Location:SSO HUB: Rare/Metastatic Cancers Zone
Shay Behrens
Belbahri, Mouloud

University of Montreal
48: Machine Learning Derived Electronic Tumor Marker Mimics Prognostic Properties of CA19-9
Location:Ballroom A
Mouloud Belbahri
Bellasea, Shay

SWOG Statistics and Data Management Center and Fred Hutchinson Cancer Research Center, Seattle, WA, USA
57: Neoadjuvant Pembrolizumab in Stage II-III Desmoplastic Melanoma (SWOG S1512): Surgical Considerations
Location:Veterans Memorial Auditorium
Shay Bellasea
Bello, Danielle

Memorial Sloan Kettering Cancer Center
Melanoma Poster Presentations 1
Location:SSO HUB Theater
Danielle Bello
The Next Generation of Vaccination Approaches to the Treatment of Cancer: mRNA and Designer Cancer Vaccines
Location:SSO HUB: Immuno-Oncology Zone
Danielle Bello
Belt, Brian

University of Rochester Medical Center
38: Semaphorin 4D is Expressed by Activated Lymphocytes in Pancreatic Adenocarcinoma, and Monoclonal Blockade Sensitizes Murine Tumors to Immune Checkpoint Therapy
Location:Ballroom B
Brian Belt
44: Pten deletion-induced murine model of cholangiocarcinoma: a pathologic and immune analysis
Location:Ballroom B
Brian Belt
46: Pan-Lysyl Oxidase Inhibition Disrupts Macrophage Invasion and Renders Tumor-Associated Macrophages Susceptible to Cytotoxic Chemotherapy in Cholangiocarcinoma
Location:Ballroom A
Brian Belt
P34: Determining Safety and Tolerability of SX-682 in Combination with Anti-PD1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma, A Phase I Study
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Brian Belt
P45: Dietary fish oil impairs melanoma growth and augments the tumor immune microenvironment in anti-PD-1 treated melanoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Brian Belt
Bende, Bence

The Ohio State University
82: Socioeconomic Disparities in the Treatment and Survival of Extremity Soft Tissue Sarcoma
Location:Ballroom B
Bence Bende
Bentrem, David

Northwestern University Feinberg School of Medicine
P70: A call for more equitable care in colon cancer: The association between racial and socioeconomic disparities and hospital quality
Location:SSO HUB: Rare/Metastatic Cancers Zone
David Bentrem
P71: Are Pathologic Factors Associated with Higher Risk for Venous Thromboembolism After Gastrointestinal Cancer Surgery? A Potential Opportunity to Tailor Prophylaxis
Location:SSO HUB: Rare/Metastatic Cancers Zone
David Bentrem
Benvenisti, Haggai

Department of General and Oncological Surgery - Surgery "C" - Chaim Sheba Medical Center
GPPO7: Perioperative and Oncological Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastasis of Rectal Origin
Location:Ballroom C
Haggai Benvenisti
Ben-Yaacov, Almog

Chaim Sheba Medical Center, Israel
Between Patient and Policy Maker - What We Can do to Build Global Capacity for Cancer Surgery
Location:Ballroom A
Almog Ben-Yaacov
Bergamaschi, Laura

Fondazione IRCCS Istituto Nazionale Tumori
P58: Immune infiltrate of primary retroperitoneal sarcomas (RPS): a prognostic study
Location:SSO HUB: Melanoma & Sarcoma Zone
Laura Bergamaschi
Berger, Adam

Rutgers Cancer Institute of New Jersey
P41: A Multi-Institution Observational Analysis of the Theory of the Immunization Effect in Patients with Multiple Primary Melanomas
Location:SSO HUB: Melanoma & Sarcoma Zone
Adam Berger
Berger, Yael

Rabin Medical Center
P80: Accuracy of Clinical Staging for Intramural (T2) Gastric Cancer: Survival Outcomes Following Upfront Surgical Resection Compared to Risk of Overtreatment with Neoadjuvant Therapy
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Yael Berger
Berger, Yaniv

University of Chicago
P53: Therapeutic Implications of Germline Testing in Peritoneal Mesothelioma
Location:SSO HUB: Rare/Metastatic Cancers Zone
Yaniv Berger
Bernard-Bedard, Ericka

Division of Surgical Oncology, Ottawa Hospital, Ottawa, Canada
77: Current Patterns of Care and Outcomes for Dermatofibrosarcoma Protuberans: An International Multi-institutional Collaborative
Location:Ballroom A
Ericka Bernard-Bedard
Berry, Charlotte

Stanford University
39: Mechanoresponsive Pancreatic Ductal Adenocarcinoma Cancer Associated Fibroblasts Shows an FAK-Dependent Subtype Divergent from Canonical Fibrotic TGFB-Pathway Dependence
Location:Ballroom B
Charlotte Berry
Bertolli, Eduardo

Hospital A. C. Camargo Cancer Center, São Paulo, Brazil
56: International Validation Study of the Melanoma Institute Australia Sentinel Node Metastasis Risk Nomogram
Location:Veterans Memorial Auditorium
Eduardo Bertolli
Bertolotti, Alessia

Fondazione IRCCS Istituto Nazionale Tumori
P58: Immune infiltrate of primary retroperitoneal sarcomas (RPS): a prognostic study
Location:SSO HUB: Melanoma & Sarcoma Zone
Alessia Bertolotti
Bianchi, Anna

University of Miami Miller School of Medicine, Department of Surgery
P32: p38 MAPK inhibition reprograms the inflammatory stroma to overcome the immunosuppressive tumor microenvironment in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Anna Bianchi
Bilchik, Anton

Providence Saint John's Cancer Institute
81: Racial and socioeconomic disparities in colorectal cancer screening during the COVID-19 pandemic
Location:Ballroom B
Anton Bilchik
Bilimoria, Karl

Indiana University School of Medicine
P71: Are Pathologic Factors Associated with Higher Risk for Venous Thromboembolism After Gastrointestinal Cancer Surgery? A Potential Opportunity to Tailor Prophylaxis
Location:SSO HUB: Rare/Metastatic Cancers Zone
Karl Bilimoria
Bjelic-Radisic, Vesna

Breast Unit, Helios University Clinic, University Witten/Herdecke, Germany
12: Impact of imaging-guided localization on performance of tailored axillary surgery in patients with clinically node-positive breast cancer: Prospective study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Vesna Bjelic-Radisic
Blakely, Andrew

Surgical Oncology Program, National Institutes of Health
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma
Location:Ballroom B
Andrew Blakely
P51: Hyperthermic intraperitoneal chemotherapy restores physiologic tumor stiffness & stimulates lymphocyte proliferation & recruitment
Location:SSO HUB: Rare/Metastatic Cancers Zone
Andrew Blakely
P54: A comparative evaluation of efficacy endpoints in colorectal and appendiceal carcinomatosis treated with PIPAC: Secondary analysis of a US multicenter phase 1 trial
Location:SSO HUB: Rare/Metastatic Cancers Zone
Andrew Blakely
P65: A National Assessment of Differences in Gastric Cancer Outcomes Among Asian Ethnic Subgroups
Location:SSO HUB: Rare/Metastatic Cancers Zone
Andrew Blakely
Blazer, Dan

Duke University Medical Center
77: Current Patterns of Care and Outcomes for Dermatofibrosarcoma Protuberans: An International Multi-institutional Collaborative
Location:Ballroom A
Dan Blazer
Regional Therapies for Soft Tissue Sarcomas
Location:SSO HUB: Melanoma & Sarcoma Zone
Dan Blazer
P29: Hepatic resection for metastatic pancreatic ductal adenocarcinoma – a prospective single institution pilot study
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Dan Blazer
P33: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Dan Blazer
P60: Evolution in management of upfront treatment for desmoid tumors
Location:SSO HUB: Melanoma & Sarcoma Zone
Dan Blazer
P79: Impact of Tumor Size and Management on Survival in Gastric GIST
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Dan Blazer
Panel: Pursuing a Career in Academia Versus Private Practice
Location:Room 302
Dan Blazer
SSO 2023 Pre-Meeting: SSO Fellows Institute II: Practical Aspects of Starting a Surgical Oncology Career (Separate Registration)
Location:Room 302
Dan Blazer
Bleicher, Richard

Fox Chase Cancer Center
14: Should patients with HR+HER2- breast cancer and 1-3 positive sentinel nodes undergo axillary dissection to determine candidacy for abemaciclib?
Location:Veterans Memorial Auditorium
Richard Bleicher
Blue, Christian

Virginia Commonwealth University School of Medicine
13: Luminal A vs B After Choosing Wisely: Do Phenotypes Affect Oncologic Outcomes?
Location:Veterans Memorial Auditorium
Christian Blue
Boe, Lillian

Memorial Sloan Kettering
19: Sexual Well-being in Patients with Breast Cancer Surgery: Trends, Associated Factors, and Interventions.
Location:Veterans Memorial Auditorium
Lillian Boe
Boerner, Thomas

Memorial Sloan Kettering Cancer Center
35: Genetic Heterogeneity of Intrahepatic Cholangiocarcinoma: Implications for Outcome
Location:Veterans Memorial Auditorium
Thomas Boerner
Boileau, Jean-Francois

Associate Professor of Surgery, McGill University, Montreal, QC, Canada; Surgical Oncologist, Segal Cancer Center, Jewish General Hospital, Montreal, Qc, Canada
P12: Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast Conserving Surgery After Neoadjuvant Chemotherapy
Location:SSO HUB: Breast & Endocrine Zone
Jean-Francois Boileau
Boland, Genevieve

Massachusetts General Hospital
Melanoma in Pregnancy - Immunotherapy Considerations
Location:SSO HUB Theater
Genevieve Boland
P48: Increased Frequency of Gene Mutations Significantly Decreases Recurrence Risk In High-Risk Stage II Melanoma Patients.
Location:SSO HUB: Melanoma & Sarcoma Zone
Genevieve Boland
The Use of Circulating Tumor DNA in the Management of Cutaneous, Thoracic and Breast Malignancies
Location:Ballroom A
Genevieve Boland
Bold, Richard

Division of Surgical Oncology, Department of Surgery, UC Davis
P37: Characterization of Natural Killer and Cytotoxic T Cell Immune Infiltrates in Pancreatic Ductal Adenocarcinoma
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Richard Bold
Bonanni, Maria

University of Pennsylvania, Medical Genetics
P25: What are the clinical implications of SDHA pathogenic variants?
Location:SSO HUB: Breast & Endocrine Zone
Maria Bonanni
Boone, Brian

West Virginia University WVU Cancer Institute WV Clinical and Translational Science Institute
104: Neoadjuvant Imatinib Permits Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor
Location:Veterans Memorial Auditorium
Brian Boone
Borghi, Alessandra

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
P64: Surgical management of the duodenum during multivisceral resection for retroperitoneal sarcoma (RPS)
Location:SSO HUB: Melanoma & Sarcoma Zone
Alessandra Borghi
Botty van den Bruele, Astrid

Duke University Hospital
P10: High Risk Screening in Women with BRCA1/2 Mutations Age 70 and Above
Location:SSO HUB: Breast & Endocrine Zone
Astrid Botty van den Bruele
Boudreaux, Philip

LSU HSC New Orleans
30: Cytoreduction in Patients with Metastatic Pancreatic Neuroendocrine Tumors and the Clinical Factors Driving Outcomes
Location:Ballroom A
Philip Boudreaux
Boughey, Judy

Mayo Clinic
1: Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer – Results from ACOSOG Z11102 (Alliance)
Location:Veterans Memorial Auditorium
Judy Boughey
3: Changes in axillary surgical management over 10 years – report on > 1400 breast cancer patients treated with neoadjuvant chemotherapy on I-SPY2
Location:Veterans Memorial Auditorium
Judy Boughey
7: Multicenter clinical trial for omission of breast surgery in invasive cancer following neoadjuvant systemic therapy: Longitudinal patient reported outcomes and decisional comfort planned analyses
Location:Veterans Memorial Auditorium
Judy Boughey
Meet the Experts: Controversies in Breast Cancer Surgery
Location:Room 302
Judy Boughey
P4: Clinical Behavior, Management and Treatment Response of Estrogen Receptor Low (1-10%) Breast Cancer by PR expression
Location:SSO HUB: Breast & Endocrine Zone
Judy Boughey
Bouvet, Michael

Department of Surgery, University of California San Diego
P83: Primary and Metastatic Gastric Cancers in Patient-derived Orthotopic Xenografts Brightly Labeled by Fluorescent anti-CEA Antibody
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Michael Bouvet
Bowles, Tawnya

Intermountain Medical Center
60: Safety, efficacy, and biomarker assessment of RP1 in combination with nivolumab in patients with advanced skin cancers
Location:Veterans Memorial Auditorium
Tawnya Bowles
Box, Edmond

University of Miami, Miller School of Medicine, Department of Surgery
P32: p38 MAPK inhibition reprograms the inflammatory stroma to overcome the immunosuppressive tumor microenvironment in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Edmond Box
Boyle, Marissa

Cedars Sinai Medical Center
18: Clinical Impact of Semi-Annual Mammography in Patients Undergoing Breast Conserving Surgery Following Neoadjuvant Therapy
Location:Veterans Memorial Auditorium
Marissa Boyle
Brady, Mary

Memorial Sloan Kettering Cancer Center
Melanoma Parallel Session
Location:Veterans Memorial Auditorium
Mary Brady
Brekken, Rolf

UT Southwestern Medical Center, Dept of Surgery
49: Stroma Selective Inhibition of TGFβ – Genomic Stratification As The Key to Overcoming Failed Clinical Translation in Pancreatic Cancer
Location:Ballroom A
Rolf Brekken
Brich, Silvia

Fondazione IRCCS Istituto Nazionale Tumori
P58: Immune infiltrate of primary retroperitoneal sarcomas (RPS): a prognostic study
Location:SSO HUB: Melanoma & Sarcoma Zone
Silvia Brich
Brognard, John

National Cancer Institute
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma
Location:Ballroom B
John Brognard
Broman, Kristy

University of Alabama at Birmingham
P41: A Multi-Institution Observational Analysis of the Theory of the Immunization Effect in Patients with Multiple Primary Melanomas
Location:SSO HUB: Melanoma & Sarcoma Zone
Kristy Broman
Brunelle, Cheryl

Massachusetts General Hospital
9: Breast cancer-related lymphedema and its relationship to major landmark trials in surgical oncology and radiation oncology
Location:Veterans Memorial Auditorium
Cheryl Brunelle
Brunton-Sim, Roxanne

Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK
62: Validation of Invasive Area for Predicting Sentinel Node Status and Survival in Melanoma
Location:Veterans Memorial Auditorium
Roxanne Brunton-Sim
Bucher, Susanne

Breast Center, Cantonal Hospital Lucerne, Lucerne, Switzerland
17: Axillary dissection to determine nodal burden to inform systemic therapy recommendations for clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Susanne Bucher
Buckarma, EeeLN

Mayo Clinic Dept Surgery
P61: Outcomes After Resection of Locally Recurrent Retroperitoneal Sarcoma
Location:SSO HUB: Melanoma & Sarcoma Zone
EeeLN Buckarma
P84: Outcomes After Minimally Invasive Gastrectomy for Locally Advanced Gastric Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
EeeLN Buckarma
Burcham, Austin

Stanford University
39: Mechanoresponsive Pancreatic Ductal Adenocarcinoma Cancer Associated Fibroblasts Shows an FAK-Dependent Subtype Divergent from Canonical Fibrotic TGFB-Pathway Dependence
Location:Ballroom B
Austin Burcham
Burchard, Paul

University of Rochester Medical Center
38: Semaphorin 4D is Expressed by Activated Lymphocytes in Pancreatic Adenocarcinoma, and Monoclonal Blockade Sensitizes Murine Tumors to Immune Checkpoint Therapy
Location:Ballroom B
Paul Burchard
44: Pten deletion-induced murine model of cholangiocarcinoma: a pathologic and immune analysis
Location:Ballroom B
Paul Burchard
46: Pan-Lysyl Oxidase Inhibition Disrupts Macrophage Invasion and Renders Tumor-Associated Macrophages Susceptible to Cytotoxic Chemotherapy in Cholangiocarcinoma
Location:Ballroom A
Paul Burchard
P34: Determining Safety and Tolerability of SX-682 in Combination with Anti-PD1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma, A Phase I Study
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Paul Burchard
P45: Dietary fish oil impairs melanoma growth and augments the tumor immune microenvironment in anti-PD-1 treated melanoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Paul Burchard
Burner, Danielle

Duke University Medical Center
P60: Evolution in management of upfront treatment for desmoid tumors
Location:SSO HUB: Melanoma & Sarcoma Zone
Danielle Burner
Burns, Brian

Emory University
55: Neoadjuvant Pepinemab in Combination with Nivolumab and/or Ipilimumab in Resectable Stage III Melanoma
Location:Veterans Memorial Auditorium
Brian Burns
Burns, William

The Johns Hopkins Department of Surgery
P75: “Next Gen” Operative Notes – synoptic operative reporting for cancer surgery
Location:SSO HUB: Rare/Metastatic Cancers Zone
William Burns
Butterfield, Richard

Department of Biostatistics, Mayo Clinic Arizona
P63: Is there a benefit to radiation and surgery in specific histologic subtypes of retroperitoneal sarcoma?
Location:SSO HUB: Melanoma & Sarcoma Zone
Richard Butterfield
Byers, Sara

University of Colorado Anschutz Medical Campus
P77: Prospective Evaluation of a Universally Applied Laparoscopic Gastric Ischemic Preconditioning Protocol Prior to Esophagectomy with Comparison to Historical Controls
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Sara Byers
Byrd, Jonathan

Carnegie Mellon University
P56: A Data Driven Approach for Individualized Risk Prediction of Serious Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Location:SSO HUB: Rare/Metastatic Cancers Zone
Jonathan Byrd